Babak Edraki

1.6k total citations
9 papers, 109 citations indexed

About

Babak Edraki is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Babak Edraki has authored 9 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Obstetrics and Gynecology, 5 papers in Reproductive Medicine and 2 papers in Surgery. Recurrent topics in Babak Edraki's work include Endometrial and Cervical Cancer Treatments (5 papers), Uterine Myomas and Treatments (3 papers) and Ovarian function and disorders (2 papers). Babak Edraki is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Uterine Myomas and Treatments (3 papers) and Ovarian function and disorders (2 papers). Babak Edraki collaborates with scholars based in United States and Puerto Rico. Babak Edraki's co-authors include Peter E. Schwartz, Richard E. Peschel, Jonathan Knisely, Bruce Turner, Kenneth B. Roberts, Ernest I. Kohorn, Lynn D. Wilson, Barry M. Kacinski, Setsuko K. Chambers and Andrew A. Gumbs and has published in prestigious journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics and Gynecologic Oncology.

In The Last Decade

Babak Edraki

9 papers receiving 105 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Babak Edraki United States	5	95	75	23	21	10	9	109
Marit Sundset Norway	4	88 0.9×	40 0.5×	52 2.3×	14 0.7×	12 1.2×	7	109
Cristina Donfrancesco Italy	6	87 0.9×	114 1.5×	41 1.8×	8 0.4×	9 0.9×	9	143
Myriam Gracia Spain	5	57 0.6×	37 0.5×	55 2.4×	31 1.5×	11 1.1×	27	115
Robert P. Edwards United States	3	49 0.5×	37 0.5×	9 0.4×	12 0.6×	11 1.1×	6	75
Jens-Peter Scharf Germany	3	102 1.1×	35 0.5×	45 2.0×	43 2.0×	7 0.7×	3	112
Arantxa Lekuona Spain	5	58 0.6×	44 0.6×	11 0.5×	22 1.0×	9 0.9×	13	69
Andrea Plaikner Germany	5	157 1.7×	108 1.4×	15 0.7×	43 2.0×	7 0.7×	14	165
Florencia Noll Argentina	4	63 0.7×	41 0.5×	11 0.5×	27 1.3×	4 0.4×	13	73
Sunanda Dhar United Kingdom	5	31 0.3×	41 0.5×	12 0.5×	15 0.7×	3 0.3×	7	59
Brynhildur Eyjólfsdóttir Norway	5	128 1.3×	77 1.0×	29 1.3×	66 3.1×	9 0.9×	12	151

Countries citing papers authored by Babak Edraki

Since Specialization

Citations

This map shows the geographic impact of Babak Edraki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Babak Edraki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Babak Edraki more than expected).

Fields of papers citing papers by Babak Edraki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Babak Edraki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Babak Edraki. The network helps show where Babak Edraki may publish in the future.

Co-authorship network of co-authors of Babak Edraki

This figure shows the co-authorship network connecting the top 25 collaborators of Babak Edraki. A scholar is included among the top collaborators of Babak Edraki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Babak Edraki. Babak Edraki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Roque, Dana M., Eric R. Siegel, Natália Buza, et al.. (2020). Randomized phase II trial of carboplatin-paclitaxel compared to carboplatin-paclitaxel-trastuzumab in advanced or recurrent uterine serous carcinomas that overexpress HER2/Neu (NCT01367002): Updated survival analysis. Gynecologic Oncology. 159. 7–8. 4 indexed citations

Sethi, Rajni, et al.. (2018). Real-time Doppler ultrasound to identify vessels and guide needle placement for gynecologic interstitial brachytherapy. Brachytherapy. 17(5). 742–746. 8 indexed citations

Sethi, Rajni, et al.. (2018). Real-Time Doppler Ultrasound to Identify Vessels and Guide Needle Placement for Gynecologic Interstitial Brachytherapy. Brachytherapy. 17(4). S114–S115. 2 indexed citations

Turner, Bruce, Jonathan Knisely, Barry M. Kacinski, et al.. (1998). Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation (192Ir) and Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 40(1). 77–84. 64 indexed citations

Edraki, Babak & Peter E. Schwartz. (1997). Fertility after conservative treatment of ovarian immature teratomas. International Journal of Gynecological Cancer. 7(3). 227–232. 2 indexed citations

Gumbs, Andrew A., Bruce Turner, Jonathan Knisely, et al.. (1996). 2101 Post-operative high dose rate vaginal apex brachytherapy in stage I endometrial adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 36(1). 327–327. 4 indexed citations

Edraki, Babak & Peter E. Schwartz. (1995). Operative laparoscopy and the gynecologic oncologist. Commentary and review. Cancer. 76(S10). 1987–1991. 12 indexed citations

Nezhat, Camran, Camran Nezhat, Farr Nezhat, et al.. (1994). The role of laparoscopy in the management of gynecologic malignancy. Seminars in Surgical Oncology. 10(6). 431–439. 12 indexed citations

Martin, Robert A., Babak Edraki, & Robert L. Norris. (1994). Ovarian hyperstimulation syndrome in the emergency department: A case report. Journal of Emergency Medicine. 12(4). 481–484. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact